The increasing interest in ingesting secretions of Australian toads, specifically the Cane frog, for their reported copyright effects, presents significant risks and challenges. While anecdotal claims portray profound visions, the fact is that these secretions include a complicated combination of compounds, including the copyright, bufotenine, and